ATE316531T1 - Kondensierte dihydrochinolinon-derivate zur hemmung von mrp1 - Google Patents

Kondensierte dihydrochinolinon-derivate zur hemmung von mrp1

Info

Publication number
ATE316531T1
ATE316531T1 AT00968314T AT00968314T ATE316531T1 AT E316531 T1 ATE316531 T1 AT E316531T1 AT 00968314 T AT00968314 T AT 00968314T AT 00968314 T AT00968314 T AT 00968314T AT E316531 T1 ATE316531 T1 AT E316531T1
Authority
AT
Austria
Prior art keywords
dihydrocinolinone
condensed
derivatives
mrp1
inhibiting mrp1
Prior art date
Application number
AT00968314T
Other languages
English (en)
Inventor
Rosanne Bonjouklian
Douglas Webb Johnson
Peter Ambrose Lander
Mark Christopher Lohman
Vinod Francis Patel
Sreenivasarao Vepachedu
Yongping Xie
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE316531T1 publication Critical patent/ATE316531T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AT00968314T 1999-10-07 2000-09-22 Kondensierte dihydrochinolinon-derivate zur hemmung von mrp1 ATE316531T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15817599P 1999-10-07 1999-10-07
US16978499P 1999-12-09 1999-12-09

Publications (1)

Publication Number Publication Date
ATE316531T1 true ATE316531T1 (de) 2006-02-15

Family

ID=26854809

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00968314T ATE316531T1 (de) 1999-10-07 2000-09-22 Kondensierte dihydrochinolinon-derivate zur hemmung von mrp1

Country Status (7)

Country Link
US (2) US6670373B1 (de)
EP (1) EP1224189B1 (de)
AT (1) ATE316531T1 (de)
AU (1) AU7824900A (de)
DE (1) DE60025744D1 (de)
PE (1) PE20010751A1 (de)
WO (1) WO2001027116A2 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7430257B1 (en) * 1998-02-12 2008-09-30 Lot 41 Acquisition Foundation, Llc Multicarrier sub-layer for direct sequence channel and multiple-access coding
JP2004529919A (ja) * 2001-04-09 2004-09-30 イーライ・リリー・アンド・カンパニー Ｍｒｐ１を阻害するための化合物および方法
CN1281210C (zh) * 2003-11-29 2006-10-25 胡汛 五味子乙素在制备治疗肿瘤药物中的应用
US20060035920A1 (en) * 2004-05-28 2006-02-16 Millennium Pharmaceuticals, Inc. Chk-1 inhibitors
US7485649B2 (en) * 2005-01-06 2009-02-03 Merck & Co., Inc. Inhibitors of checkpoint kinases
JO3672B1 (ar) 2008-12-15 2020-08-27 Regeneron Pharma أجسام مضادة بشرية عالية التفاعل الكيماوي بالنسبة لإنزيم سبتيليسين كنفرتيز بروبروتين / كيكسين نوع 9 (pcsk9).
JO3417B1 (ar) 2010-01-08 2019-10-20 Regeneron Pharma الصيغ المستقرة التي تحتوي على الأجسام المضادة لمضاد مستقبل( interleukin-6 (il-6r
RU2592694C2 (ru) 2010-08-18 2016-07-27 СЭМЬЮМЕД, ЭлЭлСи Дикетоны и гидроксикетоны в качестве активатора сигнального пути катенина
SG192117A1 (en) 2011-01-28 2013-08-30 Sanofi Sa Human antibodies to pcsk9 for use in methods of treating particular groups of subjects
AR087305A1 (es) 2011-07-28 2014-03-12 Regeneron Pharma Formulaciones estabilizadas que contienen anticuerpos anti-pcsk9, metodo de preparacion y kit
TWI589299B (zh) 2011-10-11 2017-07-01 再生元醫藥公司 用於治療類風濕性關節炎之組成物及其使用方法
WO2013059548A1 (en) 2011-10-19 2013-04-25 Sanofi Compositions and methods for treating cancer using jak2 inhibitor
JO3370B1 (ar) 2011-11-10 2019-03-13 Regeneron Pharma طريقة لتثبيط نمو الورم عن طريق تثبيط مستقبل انترلوكين 6
DK2968249T3 (en) 2013-02-22 2019-03-04 Samumed Llc GAMMA DIKETONS AS WNT / BETA-CATENIN SIGNAL ROAD ACTIVATORS
CN118105480A (zh) 2013-11-12 2024-05-31 赛诺菲生物技术公司 用于与pcsk9抑制剂一起使用的给药方案
DE202014010499U1 (de) 2013-12-17 2015-10-20 Kymab Limited Targeting von humaner PCSK9 zur Cholesterinbehandlung
US9017678B1 (en) 2014-07-15 2015-04-28 Kymab Limited Method of treating rheumatoid arthritis using antibody to IL6R
WO2015116852A1 (en) 2014-01-29 2015-08-06 Regeneron Pharmaceuticals, Inc. Methods for treating rheumatoid arthritis by administering an il-6r antibody
MA40454B1 (fr) 2014-08-20 2020-01-31 Samumed Llc Gamma-dicétones pour le traitement et la prévention des rides et du vieillissement de la peau
JP2018523684A (ja) 2015-08-18 2018-08-23 リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． リポタンパク質アフェレーシスを受けている高脂血症の患者を治療するための抗ｐｃｓｋ９阻害抗体
EP3495351A1 (de) * 2017-12-08 2019-06-12 Solvay Sa Oxidation einer pyrazolylketon verbindung zur entsprechenden carboxysäure
SG11202101674QA (en) 2018-08-29 2021-03-30 Regeneron Pharma Methods and compositions for treating subjects having rheumatoid arthritis
MA54861A (fr) 2019-01-31 2021-12-08 Regeneron Pharma Anticorps anti-récepteur de l'il6 pour traiter l'arthrite idiopathique juvénile
SG11202111742QA (en) 2019-04-24 2021-11-29 Sanofi Biotechnology Methods of diagnosis and treatment of rheumatoid arthritis
CA3142710A1 (en) 2019-06-04 2020-12-10 Sanofi Biotechnology Compositions and methods for treating pain in subjects with rheumatoid arthritis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5182290A (en) * 1991-08-27 1993-01-26 Neurogen Corporation Certain oxazoloquinolinones; a new class of GABA brain receptor ligands
US5717092A (en) 1996-03-29 1998-02-10 Vertex Pharmaceuticals Inc. Compounds with improved multi-drug resistance activity
PL343313A1 (en) * 1998-04-08 2001-08-13 Lilly Co Eli Methods for inhibiting mrp1

Also Published As

Publication number Publication date
WO2001027116A3 (en) 2001-11-22
US6670373B1 (en) 2003-12-30
WO2001027116A2 (en) 2001-04-19
AU7824900A (en) 2001-04-23
PE20010751A1 (es) 2001-07-18
EP1224189B1 (de) 2006-01-25
DE60025744D1 (de) 2006-04-13
US20040077675A1 (en) 2004-04-22
EP1224189A2 (de) 2002-07-24

Similar Documents

Publication Publication Date Title
DE60025744D1 (de) Kondensierte dihydrochinolinon-derivate zur hemmung von mrp1
CY1109886T1 (el) Καινοφανεις ενωσεις ως αντι-φλεγμονωδεις, ανοσοτροποποιητικοι και αντι υπερπλαστικοι παραγοντες
CY1108567T1 (el) Αντιθρομβωτικες ενωσεις
EA200300528A1 (ru) 1-арил-или 1-алкилсульфонилгетероциклилбензазолы в качестве лигандов 5-гидрокситриптамина-6
BR9804214A (pt) Compostos.
BR0210030A (pt) Derivado de fenilpiridinacarbonilpiperazina
BRPI0417543A (pt) quinolinas úteis no tratamento de doença cardiovascular
DE60123933D1 (de) Fluoreszierende proben zur quantitativen bestimmung von zink
ATE231149T1 (de) (1,8)-naphthyridinderivate derivate mit antiviraler wirkung
BRPI0413973A (pt) compostos
PE20011085A1 (es) Compuestos isoxazolquinolin o imidazolquinolin como inhibidores de la proteina resistente a multifarmacos
ATE503746T1 (de) Neue imidazolidinderivate
BR0115210A (pt) Derivado de pirimidina e produto herbicida contendo o mesmo
EA200300629A1 (ru) Конденсированные производные пурина как антагонисты рецепторов аденозина a
ATE411287T1 (de) Neue metallproteinaseinhibitoren
EA200301317A1 (ru) Производные аминохинолина и его применение в качестве лигандов аденозина a3
BR0014990A (pt) Derivados de tetrahidrotiopirano ranftalazinona como inibidores de pde4
TR200002851T2 (tr) MRP1'i inhibe etmek için yöntemler.
DE60041001D1 (de) Substituierte homopiperidylbenzimidazolanaloga als fundusrelaxantien
BRPI0416678A (pt) pirazolpirimidinas
TR200002803T2 (tr) MRP1 inhibe etmek için yöntemler.
ATE278697T1 (de) Katalysatoren
TR200002804T2 (tr) MRP1 inhibe etmek için yöntemler
MY129094A (en) Condensed polycyclic compounds
ATE276259T1 (de) Dihydroporphyrinderivate und ihre verwendung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties